Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078492607> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2078492607 endingPage "1740" @default.
- W2078492607 startingPage "1736" @default.
- W2078492607 abstract "Intravenous immunoglobulins (IvIgG) are often used in patients receiving a basic immunosuppressive therapy with CsA either for prevention of infectious complications or as an additional prophylaxis of graft versus host disease in clinical bone marrow transplantation. As far as we know, the combined in vitro immunosuppressive effects of these 2 drugs have not been investigated yet. In this study, we compared the effect of CsA, IvIgG, and CsA combined with IvIgG on the proliferative capacity of peripheral blood mononuclear cells in a mixed lymphocyte culture system. The concentrationdependent inhibition of peripheral blood mononuclear cell proliferation in the mixed lymphocyte culture system by CsA is a well established phenomenon. By adding IvIgG to the cultures (n=20) containing CsA, we were able to show a significantly (P<0.0002) higher inhibition compared with the inhibitory capacity of CsA alone. Cyclosporine A was added to the cultures at concentrations ranging from 25 to 400 ng/ml, and IvIgG was added in 3 different fixed concentrations: 1.25, 2.5, and 5 mg/ml. These are all concentrations which one usually obtains in patients during therapy with these drugs. Even with a minimal concentration of CsA (25 ng/ml) plus IvIgG (1.25 mg/ml), we achieved a mean inhibition of 77.7±7.9%, which is in the range of the mean inhibition (84.3±4.7%) with the highest concentration of CsA (400 ng/ml) tested. Our in vitro results could suggest that the additional therapy with IvIgG in patients receiving CsA might cause a CsA sparing effect. This might lead to a combined therapeutic regimen with a good immunosuppressive efficacy and minimal drug associated adverse effects." @default.
- W2078492607 created "2016-06-24" @default.
- W2078492607 creator A5000168086 @default.
- W2078492607 creator A5006763905 @default.
- W2078492607 creator A5061287044 @default.
- W2078492607 date "1996-06-01" @default.
- W2078492607 modified "2023-10-17" @default.
- W2078492607 title "ADDITIONAL INHIBITORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS IN COMBINATION WITH CYCLOSPORINE A ON HUMAN T LYMPHOCYTE ALLOPROLIFERATIVE RESPONSE IN VITRO" @default.
- W2078492607 cites W1965554246 @default.
- W2078492607 cites W1979105454 @default.
- W2078492607 cites W2002658043 @default.
- W2078492607 cites W2005873886 @default.
- W2078492607 cites W2022995658 @default.
- W2078492607 cites W2035942340 @default.
- W2078492607 cites W2060404652 @default.
- W2078492607 cites W2072254606 @default.
- W2078492607 cites W2076380468 @default.
- W2078492607 cites W2080064179 @default.
- W2078492607 cites W2083705563 @default.
- W2078492607 cites W2093173647 @default.
- W2078492607 cites W2142495802 @default.
- W2078492607 cites W2151305184 @default.
- W2078492607 cites W2312692625 @default.
- W2078492607 cites W2336197601 @default.
- W2078492607 cites W2341400992 @default.
- W2078492607 cites W266899744 @default.
- W2078492607 cites W4255940022 @default.
- W2078492607 doi "https://doi.org/10.1097/00007890-199606270-00013" @default.
- W2078492607 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8685953" @default.
- W2078492607 hasPublicationYear "1996" @default.
- W2078492607 type Work @default.
- W2078492607 sameAs 2078492607 @default.
- W2078492607 citedByCount "12" @default.
- W2078492607 crossrefType "journal-article" @default.
- W2078492607 hasAuthorship W2078492607A5000168086 @default.
- W2078492607 hasAuthorship W2078492607A5006763905 @default.
- W2078492607 hasAuthorship W2078492607A5061287044 @default.
- W2078492607 hasBestOaLocation W20784926071 @default.
- W2078492607 hasConcept C126322002 @default.
- W2078492607 hasConcept C137061746 @default.
- W2078492607 hasConcept C159654299 @default.
- W2078492607 hasConcept C185592680 @default.
- W2078492607 hasConcept C202751555 @default.
- W2078492607 hasConcept C203014093 @default.
- W2078492607 hasConcept C2777761686 @default.
- W2078492607 hasConcept C2911091166 @default.
- W2078492607 hasConcept C55493867 @default.
- W2078492607 hasConcept C71924100 @default.
- W2078492607 hasConcept C98274493 @default.
- W2078492607 hasConceptScore W2078492607C126322002 @default.
- W2078492607 hasConceptScore W2078492607C137061746 @default.
- W2078492607 hasConceptScore W2078492607C159654299 @default.
- W2078492607 hasConceptScore W2078492607C185592680 @default.
- W2078492607 hasConceptScore W2078492607C202751555 @default.
- W2078492607 hasConceptScore W2078492607C203014093 @default.
- W2078492607 hasConceptScore W2078492607C2777761686 @default.
- W2078492607 hasConceptScore W2078492607C2911091166 @default.
- W2078492607 hasConceptScore W2078492607C55493867 @default.
- W2078492607 hasConceptScore W2078492607C71924100 @default.
- W2078492607 hasConceptScore W2078492607C98274493 @default.
- W2078492607 hasIssue "12" @default.
- W2078492607 hasLocation W20784926071 @default.
- W2078492607 hasLocation W20784926072 @default.
- W2078492607 hasLocation W20784926073 @default.
- W2078492607 hasOpenAccess W2078492607 @default.
- W2078492607 hasPrimaryLocation W20784926071 @default.
- W2078492607 hasRelatedWork W1975729558 @default.
- W2078492607 hasRelatedWork W2000373946 @default.
- W2078492607 hasRelatedWork W2073641733 @default.
- W2078492607 hasRelatedWork W2085854818 @default.
- W2078492607 hasRelatedWork W2402307906 @default.
- W2078492607 hasRelatedWork W2403656428 @default.
- W2078492607 hasRelatedWork W2748952813 @default.
- W2078492607 hasRelatedWork W2899084033 @default.
- W2078492607 hasRelatedWork W4360592424 @default.
- W2078492607 hasRelatedWork W2031164417 @default.
- W2078492607 hasVolume "61" @default.
- W2078492607 isParatext "false" @default.
- W2078492607 isRetracted "false" @default.
- W2078492607 magId "2078492607" @default.
- W2078492607 workType "article" @default.